Neuromuscular Diseases
-
Neuromuscular Diseases
Subcutaneous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy – Neurologist, Nursing and Patient Perspectives
Vera Bril, James Babington Smith, Dorothea Grosse-Kreul, Melody Bullock, Jeffrey A Allen, Thomas Harbo, Richard A Lewis, Hans KatzbergEuropean Neurological Review. 2019:14(1):44–9. DOI: https://doi.org/10.17925/ENR.2019.14.1.44 -
Neuromuscular Diseases
Aksel Siva, AAN 2019 – Diagnosis and treatment of neuro-Behçet disease (Part 2)
-
Neuromuscular Diseases
Aksel Siva, AAN 2019 – Diagnosis and treatment of neuro-Behçet disease (Part 1)
-
Neuromuscular Diseases
Said Beydoun, AAN 2019 – Current and emerging therapies for myasthenia gravis (Part 2)
-
Neuromuscular Diseases
Said Beydoun, AAN 2019 – Current and emerging therapies for myasthenia gravis (Part 1)
-
Neuromuscular Diseases
Challenges of Interpreting Dystrophin Content by Western Blot
Frederick J Schnell, Diane Frank, Sue Fletcher, Russell D Johnsen, Steve D WiltonUS Neurology. 2019;15(1):40–6 -
Neuromuscular Diseases
Existing and Emerging Approaches to Treating Chronic Inflammatory Demyelinating Polyneuropathy
Thomas H Brannagan III, Khosro Farhad, Inna Kleyman, Megan Leitch, Rebecca Traub, Christina UlaneUS Neurology. 2019;15(1):33–9 -
Neuromuscular Diseases
Neuro-Behçet’s Disease – Clinical Features, Diagnosis and Differential Diagnosis
Selen Ozyurt, Petros Sfikakis, Aksel Siva, Cris S ConstantinescuEuropean Neurological Review. 2018;13(2):93–7 DOI: https://doi.org/10.17925/ENR.2018.13.2.93 -
Neuromuscular Diseases
Myasthenia Gravis – A Review of Current Therapeutic Options
Saiju JacobEuropean Neurological Review. 2018;13(2):86–92 DOI: https://doi.org/10.17925/ENR.2018.13.2.86 -
Neuromuscular Diseases
The Potential Misdiagnosis of Multifocal Motor Neuropathy as Amyotrophic Lateral Sclerosis—A Case Series
Victoria Lawson, Nathaniel M RobbinsUS Neurology. 2018;14(2):102–7 DOI: https://doi.org/10.17925/USN.2018.14.2.102 -
Neuromuscular Diseases
Late-onset Hereditary Transthyretin Amyloidosis in Two Patients with Acquired Demyelinating Features
Nazila Rad, Said R BeydounUS Neurology. 2018;14(2):98–101 DOI: https://doi.org/10.17925/USN.2018.14.2.98 -
Neuromuscular Diseases
Descriptive Characteristics of Males with Duchenne Muscular Dystrophy in Those Covered by Government (Medicaid) and Non-government (Private) Health Plans
Oscar H Mayer, John Karafilidis, Kate Higgins, Brian GriffinUS Neurology. 2018;14(2):88–93 DOI: https://doi.org/10.17925/USN.2018.14.2.88 -
Neuromuscular Diseases
The Challenge of Distinguishing POEMS from Chronic Inflammatory Demyelinating Polyneuropathy—Importance of Early Recognition and Diagnosis of POEMS
Frances Chow, Leila Darki, Said R BeydounUS Neurology. 2018;14(2):94–7 DOI: https://doi.org/10.17925/USN.2018.14.2.94 -
Neuromuscular Diseases
Refractory Myasthenia Gravis – Patient Burden and the Need for New Therapeutic Targets
Saiju JacobEuropean Neurological Review. 2018;13(1):18–20 DOI: https://doi.org/10.17925/ENR.2018.13.1.18 -
Neuromuscular Diseases
Highlights from the 70th Annual AAN Meeting 2018: focus on spinal muscular atrophy
